NEW! iPSC Virtual Demo Hub | A tour of our labs and technology

Enjoy a new 15 minute virtual demonstration from within Solentim’s laboratories and download resources to learn how our new workflow for iPSC seeding can help you overcome challenges associated with iPSC workflows. iPSCs have practically an unlimited proliferation potential, and a capability to differentiate into any cell type in the human body. Because of this, …

Read more NEW! iPSC Virtual Demo Hub | A tour of our labs and technology

A vision of a Cell Line Development Ecosystem: New White Paper

Cell Line Development (CLD) is a required process within therapeutic antibody development, a journey made by single high value cells, through growth, selection and ultimately to cell banking. Decision making at each step requires information derived from different technologies, traditionally disparate, unconnected platforms. Understanding and managing the quality of this data and moreover, following the data …

Read more A vision of a Cell Line Development Ecosystem: New White Paper

High accuracy confluency measurements in cell line development using Solentim’s ICON instrument: New Application Note

Confluency, the percent area of a microplate well visually covered by cells, is used in cell biology as a trigger for key events including initiation of cell-based assays, transfection and passaging. An artificial neural network is a scalable, adaptive structure that when compared to traditional image processing methods has the advantages of being able to …

Read more High accuracy confluency measurements in cell line development using Solentim’s ICON instrument: New Application Note

Cell line development partners deliver technology breakthrough

A project consortium involving Solentim, ValitaCell and Microcoat has successfully developed an integrated technology platform for biologics and cell therapy. In 2019, the consortium partners raised €3.5M to advance the project which has culminated in the launch of the ICON™ instrument by Solentim. ICON™ is designed to enhance commercial laboratory workflows involved in development of new therapeutic antibodies. …

Read more Cell line development partners deliver technology breakthrough

ICON™ offers low volume titer and cell counting assays enabling productivity measurements earlier in the process.

The measurement of productivity (antibody titer per cell) is a key critical quality attribute in the selection of high value clones in cell line development (CLD). The CLD workflow starts with small volumes before moving through to higher volume plates then flasks. The use of productivity measurements is often frustrated by existing instrumentation which require …

Read more ICON™ offers low volume titer and cell counting assays enabling productivity measurements earlier in the process.